April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Cell-Associated Urokinase Regulates Integrin vβ5 Expression and Myofibroblast Differentiation
Author Affiliations & Notes
  • A. M. Bernstein
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • L. Wang
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • A. Garcia
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • B. S. Pedroja
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • Footnotes
    Commercial Relationships  A.M. Bernstein, None; L. Wang, None; A. Garcia, None; B.S. Pedroja, None.
  • Footnotes
    Support  R01 EY017030 and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6421. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. M. Bernstein, L. Wang, A. Garcia, B. S. Pedroja; Cell-Associated Urokinase Regulates Integrin vβ5 Expression and Myofibroblast Differentiation. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6421.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The persistence of myofibroblasts in corneal scars leads to the accumulation of extracellular matrix (ECM). The uPA/uPAR (urokinase plasminogen activator/receptor) protease system controls ECM through the generation of plasmin. Previously we showed that maintaining cell surface uPA/uPAR expression inhibited myofibroblast differentiation. In this study we demonstrate that integrin αvβ5 is a uPA/uPAR-binding partner through which myofibroblast differentiation is modulated.

Methods: : Human corneal fibroblasts were grown on collagen in supplemented serum-free media. Western blotting and qPCR determined expression of integrin αvβ5 and α-smooth muscle actin (α-SMA). Transfection with control, WT and non-cleavable (NC) uPAR cDNA, uPA and uPAR siRNA, were performed by Nucleofection. uPA activity was determined using a chromogenic activity assay. TGFβ activity was determined using a luciferase reporter assay. Myofibroblast differentiation was determined by immunostaining for α-SMA.

Results: : To determine if uPA activity directly affects β5 expression, uPA activity was inhibited with an anti-uPA antibody, resulting in a 1.7 fold increase in β5 expression. Furthermore, uPA and uPAR siRNA knockdown resulted in a 2-3-fold increase in αvβ5 RNA and protein expression, a 2-fold increase in TGFβ activity and induction of myofibroblast differentiation without TGFβ addition. uPAR cleavage of its Domain 1 abolishes uPA binding. Thus, to determine if maintaining uPA on the cell surface reduced β5, a NC uPAR mutant cDNA was over-expressed, resulting in a 60% reduction of β5. Furthermore, Plasminogen Activator Inhibitor-1 (PAI-1) null fibroblasts in which PA activity is unregulated had a 3-fold decrease in β5 expression in parallel with a 3-fold increase in PA activity. Finally, over 7 days in culture with TGFβ as myofibroblast differentiation is induced, β5 was dramatically upregulated as uPAR was reciprocally downregulated, whereas blocking αvβ5 reduced myofibroblast differentiation.

Conclusions: : Together these data demonstrate that maintaining cell-surface uPA controls integrin αvβ5 expression, which in turn modulates TGFβ activity and myofibroblast differentiation.

Keywords: cornea: stroma and keratocytes • wound healing • differentiation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×